Skip to Main Content

Paper Details

A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease).
Orphanet J Rare Dis
4
2020
GM2 gangliosidosis, Patient, Tay-Sachs and Sandhoff Disease, patient, patients
Author NameAffiliation
Camilo ToroOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
Cynthia J TifftOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
Cynthia J TifftOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
  • 1 - 3

Datasets

Release 1.2